These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8228331)
21. Keratinocyte CDw60 expression is modulated by both a Th-1 type cytokine IFN-gamma and Th-2 cytokines IL-4 and IL-13: relevance to psoriasis. Huang BB; Bonish BK; Chaturvedi V; Qin JZ; Nickoloff BJ J Invest Dermatol; 2001 Feb; 116(2):305-12. PubMed ID: 11180008 [TBL] [Abstract][Full Text] [Related]
22. T cells involved in psoriasis vulgaris belong to the Th1 subset. Schlaak JF; Buslau M; Jochum W; Hermann E; Girndt M; Gallati H; Meyer zum Büschenfelde KH; Fleischer B J Invest Dermatol; 1994 Feb; 102(2):145-9. PubMed ID: 8106745 [TBL] [Abstract][Full Text] [Related]
23. The role of immune system in the pathogenesis of psoriasis. Baadsgaard O; Fisher G; Voorhees JJ; Cooper KD J Invest Dermatol; 1990 Nov; 95(5 Suppl):32S-34S. PubMed ID: 16788627 [TBL] [Abstract][Full Text] [Related]
24. Altered keratin 17 peptide ligands inhibit in vitro proliferation of keratinocytes and T cells isolated from patients with psoriasis. Shen Z; Chen L; Liu YF; Gao TW; Wang G; Fan XL; Fan JY; Fan PS; Li CY; Liu B; Dang YP; Li CX J Am Acad Dermatol; 2006 Jun; 54(6):992-1002. PubMed ID: 16713453 [TBL] [Abstract][Full Text] [Related]
25. Characterization of lesional psoriatic skin T lymphocyte clones. Barna M; Snijdewint FG; van der Heijden FL; Bos JD; Kapsenberg ML Acta Derm Venereol Suppl (Stockh); 1994; 186():9-11. PubMed ID: 8073850 [TBL] [Abstract][Full Text] [Related]
26. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Ockenfels HM; Schultewolter T; Ockenfels G; Funk R; Goos M Br J Dermatol; 1998 Sep; 139(3):390-5. PubMed ID: 9767281 [TBL] [Abstract][Full Text] [Related]
27. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation. Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697 [TBL] [Abstract][Full Text] [Related]
28. Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. Echchakir H; Bagot M; Dorothée G; Martinvalet D; Le Gouvello S; Boumsell L; Chouaib S; Bensussan A; Mami-Chouaib F J Invest Dermatol; 2000 Jul; 115(1):74-80. PubMed ID: 10886511 [TBL] [Abstract][Full Text] [Related]
29. Activation of ribosomal protein S6 kinase in psoriatic lesions and cultured human keratinocytes by epidermal growth factor receptor ligands. Choi JH; O'Connor TP; Kang S; Voorhees JJ; Fisher GJ J Invest Dermatol; 1997 Jan; 108(1):98-102. PubMed ID: 8980296 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. Teunissen MB; Koomen CW; de Waal Malefyt R; Wierenga EA; Bos JD J Invest Dermatol; 1998 Oct; 111(4):645-9. PubMed ID: 9764847 [TBL] [Abstract][Full Text] [Related]
31. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. Uyemura K; Yamamura M; Fivenson DF; Modlin RL; Nickoloff BJ J Invest Dermatol; 1993 Nov; 101(5):701-5. PubMed ID: 7693825 [TBL] [Abstract][Full Text] [Related]
32. Keratinocyte growth regulation by the products of immune cells. Hancock GE; Kaplan G; Cohn ZA J Exp Med; 1988 Oct; 168(4):1395-402. PubMed ID: 2459297 [TBL] [Abstract][Full Text] [Related]
34. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation. An J; Li Z; Dong Y; Ren J; Huo J Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949 [TBL] [Abstract][Full Text] [Related]
35. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Gattorno M; Facchetti P; Ghiotto F; Vignola S; Buoncompagni A; Prigione I; Picco P; Pistoia V Clin Exp Immunol; 1997 Jul; 109(1):4-11. PubMed ID: 9218817 [TBL] [Abstract][Full Text] [Related]
36. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242 [TBL] [Abstract][Full Text] [Related]
37. In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro. Pasch MC; Timár KK; van Meurs M; Heydendael VM; Bos JD; Laman JD; Asghar SS J Pathol; 2004 Jul; 203(3):839-48. PubMed ID: 15221944 [TBL] [Abstract][Full Text] [Related]
38. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions. Liu R; Yang Y; Yan X; Zhang K Eur J Dermatol; 2013; 23(5):600-7. PubMed ID: 24135516 [TBL] [Abstract][Full Text] [Related]
39. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation. Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384 [TBL] [Abstract][Full Text] [Related]
40. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. Krueger JG; Krane JF; Carter DM; Gottlieb AB J Invest Dermatol; 1990 Jun; 94(6 Suppl):135S-140S. PubMed ID: 2161887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]